tradingkey.logo

Capricor Therapeutics Provides Regulatory Update On Deramiocel BLA For Duchenne Muscular Dystrophy

ReutersJul 11, 2025 10:32 AM

- Capricor Therapeutics Inc CAPR.O:

  • CAPRICOR THERAPEUTICS PROVIDES REGULATORY UPDATE ON DERAMIOCEL BLA FOR DUCHENNE MUSCULAR DYSTROPHY

  • CAPRICOR THERAPEUTICS INC - FDA ISSUES COMPLETE RESPONSE LETTER TO CAPRICOR

  • CAPRICOR THERAPEUTICS INC - TO RESUBMIT BLA WITH PHASE 3 DATA IN Q3 2025

  • CAPRICOR THERAPEUTICS INC - FDA ADVISES CAPRICOR TO REQUEST MEETING FOR APPROVAL

  • CAPRICOR THERAPEUTICS: FDA SAID DERAMIOCEL BLA DOES NOT MEET STATUTORY REQUIREMENT FOR SUBSTANTIAL EVIDENCE OF EFFECTIVENESS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI